Aprea Therapeutics, Inc. (APRE)

Investing Cash Flow

-$15.75K

Quarterly · Period ending: · USD

APRE logo

APRE Investing Cash Flow

Latest reported-$15.75K
APRE Quarterly Cash from Investing ($228.00 → -$15.75K)
High-resolution chart · PNG

APRE investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-15,748
0
0
0
0
0
0
0
-7,500
-7,978
-7,150
-85,943
0
0
0
0
0
0
0
0
0
0
-16,290
155
2,021
-12,165
-14,333
-10,246
-6,189
0
804
228
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.